OTCMKTS:OCPNY Olympus (OCPNY) Stock Price, News & Analysis $18.00 -0.25 (-1.37%) (As of 01/31/2023) Add Compare Share Share Today's Range$18.00▼$18.0050-Day Range$18.00▼$18.0052-Week Range$16.80▼$74.99Volume400 shsAverage Volume860,265 shsMarket Capitalization$23.15 billionP/E Ratio21.95Dividend Yield0.44%Price TargetN/A Stock AnalysisStock Analysis Get Olympus alerts: Email Address Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! About Olympus Stock (OTCMKTS:OCPNY)Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.Read More OCPNY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OCPNY Stock News HeadlinesJuly 25 at 4:18 AM | americanbankingnews.comOlympus (OTCMKTS:OCPNY) Stock Passes Below Two Hundred Day Moving Average of $18.00July 17, 2024 | americanbankingnews.comOlympus (OTCMKTS:OCPNY) Stock Crosses Below 200 Day Moving Average of $18.00July 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.May 11, 2023 | finance.yahoo.comTim Stroble Appointed as Olympus Insurance Company Chief Executive OfficerFebruary 26, 2023 | bizjournals.comNew Olympus sports complex partnership is latest in $1B+ project's progressFebruary 23, 2023 | thestreet.comOlympus Teams Up With Sony for Surgical Big Screen TVJanuary 12, 2023 | seekingalpha.comOlympus says addressing FDA concerns on endoscope productionJanuary 9, 2023 | finance.yahoo.comOlympus Corporation (OCPNY) Stock Historical Prices & Data - Yahoo FinanceJuly 26, 2024 | Unstoppable Prosperity (Ad)“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event.November 12, 2022 | seekingalpha.comOlympus Corporation (OCPNY) Q3 2022 Earnings Call TranscriptOctober 21, 2022 | benzinga.comOlympus Announces Leadership Succession PlanOctober 9, 2022 | reuters.comOCPNY.PK - | Stock Price & Latest News | ReutersAugust 30, 2022 | finance.yahoo.comWhat Makes Olympus Corp. (OCPNY) a Good Fit for "Trend Investing"August 11, 2022 | finance.yahoo.comHere's Why Momentum in Olympus Corp. (OCPNY) Should Keep goingAugust 9, 2022 | seekingalpha.comOlympus Corporation (OCPNY) Management on Q1 2023 Results - Earnings Call TranscriptJuly 28, 2022 | finance.yahoo.comHere's Why Olympus Corp. (OCPNY) is a Great Momentum Stock to BuyApril 23, 2022 | seekingalpha.comClearBridge Investments Global Growth Strategy Q1 2022 CommentaryApril 14, 2022 | seekingalpha.comClearBridge International Growth ADR Strategy Portfolio Manager Commentary Q1 2022See More Headlines Receive OCPNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/05/2021Today7/26/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Structural clay products Sub-IndustryN/A Current SymbolOTCMKTS:OCPNY CUSIPN/A CIKN/A Webwww.olympus-global.com Phone(133) 340-2111Fax813-3340-2062Employees31,557Year Founded1919Profitability EPS (Most Recent Fiscal Year)$0.82 Trailing P/E Ratio21.95 Forward P/E Ratio10.91 P/E Growth1.07Net Income$1.03 billion Net Margins13.80% Pretax MarginN/A Return on Equity24.30% Return on Assets9.30% Debt Debt-to-Equity Ratio0.59 Current Ratio1.99 Quick Ratio1.48 Sales & Book Value Annual Sales$7.74 billion Price / Sales2.99 Cash Flow$1.22 per share Price / Cash Flow14.76 Book Value$3.50 per share Price / Book5.14Miscellaneous Outstanding Shares1,285,890,000Free FloatN/AMarket Cap$23.15 billion OptionableNot Optionable Beta0.70 Social Links Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesYasuo TakeuchiPresident, Chief Executive Officer & DirectorNacho AbiaChief Operating OfficerChikashi TakedaChief Financial OfficerAndré RogganExecutive Officer & Chief Technology OfficerStephen Mark KneeboneChief Information Officer & Executive OfficerKey CompetitorsHCA HealthcareNYSE:HCAGilead SciencesNASDAQ:GILDBristol-Myers SquibbNYSE:BMYZoetisNYSE:ZTSGSKNYSE:GSKView All Competitors Should I Buy Olympus Stock? OCPNY Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Olympus Co.: Olympus Corp. has a diversified business model with operations in medical, scientific solutions, imaging, and other segments, reducing dependency on a single sector. The company's focus on precision machineries and instruments, especially in the medical segment, positions it well in the growing healthcare industry. Olympus Corp. has a long history of innovation and expertise in endoscopic technology, which is crucial in the medical field for diagnostic and therapeutic procedures. Recent financial reports show a steady revenue growth trend, indicating the company's ability to generate consistent income. With a current stock price that reflects the company's potential for growth, investors may find Olympus Co. stock to be attractively valued. Cons Investors should be bearish about investing in Olympus Co. for these reasons: The structural clay products industry, where Olympus Co. is categorized, may face challenges related to market demand and competition, impacting the company's growth prospects. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Monday, July 1, 2024. Please send any questions or comments about these Olympus pros and cons to contact@marketbeat.com. OCPNY Stock Analysis - Frequently Asked Questions How have OCPNY shares performed this year? Olympus' stock was trading at $18.00 at the beginning of the year. Since then, OCPNY shares have increased by 0.0% and is now trading at $18.00. View the best growth stocks for 2024 here. How were Olympus' earnings last quarter? Olympus Co. (OTCMKTS:OCPNY) issued its quarterly earnings results on Thursday, August, 5th. The company reported $0.13 earnings per share for the quarter, beating analysts' consensus estimates of $0.10 by $0.03. The company had revenue of $1.75 billion for the quarter, compared to the consensus estimate of $1.49 billion. Olympus had a net margin of 13.80% and a trailing twelve-month return on equity of 24.30%. Does Olympus have any subsidiaries? Olympus subsidiaries include FH ORTHO SAS, Arc Medical Design Limited, Image Stream Medical Inc, Spirus Medical Inc., Innov-X Systems Inc., Advalytix AG, AIZU OLYMPUS CORPORATION, and more. How do I buy shares of Olympus? Shares of OCPNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:OCPNY) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Olympus Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Olympus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
